Ginsenoside-Rd exhibits anti-inflammatory activities through elevation of antioxidant enzyme activities and inhibition of JNK and ERK activation in vivo

International Immunopharmacology

Volumn 17, Issue 4, 2013, Pages 1094-1100

  Zhang, Yun Xin ^a,b   Wang, Li ^a   Xiao, Er Long ^a   Li, Si Jia ^a   Chen, Jia Jia ^a   Gao, Bei ^c   Min, Guang Ning ^a   Wang, Zhi Ping ^a   Wu, Yong Jie ^a  

^a LANZHOU UNIVERSITY   (China)

^b Key Laboratory for Gastrointestinal Disease of Gansu Province   (China)

^c GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

Antioxidant enzymes; Cyclooxygenase 2 (COX 2); Ginsenoside Rd; Inducible nitric oxide synthase (iNOS); Mitogen activated protein kinases (MAPKs); Nuclear factor B (NF B)

Indexed keywords

CATALASE; CYCLOOXYGENASE 2; DEXAMETHASONE; ENZYME; GINSENOSIDE RD; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; NITRIC OXIDE; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; LIPID PEROXIDATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CATALASE; CYCLOOXYGENASE 2; DINOPROSTONE; EDEMA; FEMALE; FOOT; GINSENOSIDES; GLUTATHIONE PEROXIDASE; MALE; MALONDIALDEHYDE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84887166458     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.10.013     Document Type: Article

References (43)

1. G.J. Huang, S.S. Huang, S.S. Lin, Y.Y. Shao, C.C. Chen, and W.C. Hou Analgesic effects and the mechanisms of anti-inflammation of ergostatrien-3beta-ol from Antrodia camphorata submerged whole broth in mice J Agric Food Chem 58 2010 7445 7452
2. C.T. Chang, S.S. Huang, S.S. Lin, S. Amagaya, H.Y. Ho, and W.C. Hou Anti-inflammatory activities of tormentic acid from suspension cells of Eriobotrya Japonicaex vivo and in vivo Food Chem 127 2011 1131 1137
3. D. Salvemini, Z.Q. Wang, D.M. Bourdon, M.K. Stern, M.G. Currie, and P.T. Manning Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema Eur J Pharmacol 303 1996 217 220
4. M. Valko, C.J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur Free radicals, metals and antioxidants in oxidative stress-induced cancer Chem Biol Interact 160 2006 1 40
5. S.S. Huang, C.S. Chiu, H.J. Chen, W.C. Hou, M.J. Sheu, and Y.C. Lin Antinociceptive activities and the mechanisms of anti-inflammation of asiatic acid in mice Evid Based Complement Alternat Med 2011 2011 1 10
6. M.H. Huang, S.S. Huang, B.S. Wang, C.H. Wu, M.J. Sheu, and W.C. Hou Antioxidant and anti-inflammatory properties of Cardiospermum halicacabum and its reference compounds ex vivo and in vivo J Ethnopharmacol 133 2011 743 750
7. A.S. Attele, J.A. Wu, and C.S. Yuan Ginseng pharmacology: multiple constituents and multiple actions Biochem Pharmacol 58 1999 1685 1693
8. W. Zhou, H. Chai, P.H. Lin, A.B. Lumsden, Q. Yao, and C.J. Chen Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease Med Sci Monit 10 2004 187 192
9. Y. Cheng, L.H. Shen, and J.T. Zhang Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action Acta Pharmacol Sin 26 2005 143 149
10. H. Liu, J. Yang, F. Du, X. Gao, X. Ma, and Y. Huang Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats Drug Metab Dispos 37 2009 2290 2298
11. L. Wang, Y.X. Zhang, Z.P. Wang, S.J. Li, G.N. Min, and L.H. Wang Inhibitory effect of ginsenoside-Rd on carrageenan-induced inflammation in rats Can J Physiol Pharmacol 90 2012 229 236
12. C.A. Winter, E.A. Risley, and G.W. Nuss Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs Proc Soc Exp Biol Med 111 1962 544 547
13. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
14. N. Ohishi, H. Ohkawa, A. Miike, T. Tatano, and K. Yagi A new assay method for lipid peroxides using a methylene blue derivative Biochem Int 10 1985 205 211
15. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
16. B. Kaminska MAPK signaling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits Biochim Biophys Acta 1754 2005 253 262
17. C.H. Hsing, M.C. Lin, P.C. Choi, W.C. Huang, J.I. Kai, and C.C. Tsai Anesthetic propofol reduces endotoxic inflammation by inhibiting reactive oxygen species-regulated Akt/IKKβ/NF-κB signaling PLoS One 6 2011 e17598
18. M. Achoui, D. Appleton, M.A. Abdulla, K. Awang, M.A. Mohd, and M.R. Mustafa In vitro and in vivo anti-inflammatory activity of 17-O- acetylacuminolide through the inhibition of cytokines. NF-κB translocation and IKKβ activity PLoS One 5 2010 e15105
19. S. Oh-ishi, I. Hayashi, M. Hayashi, K. Yamaki, and I. Utsunomiya Pharmacological demonstration of inflammatory mediators using experimental inflammatory models: rat pleurisy induced by carrageenin and phorbol myristate acetate Dermatologica 179 1989 68 71
20. J. Dawson, A.D. Sedgwick, J.C. Edwards, and P. Lees A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse Int J Tissue React 13 1991 171 185
21. B.M. Peskar, M. Trautmann, P. Nowak, and B.A. Peskar Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenan-induced inflammation: effect of non-steroidal anti-inflammatory drugs Agents Actions 33 1991 240 246
22. S. Cuzzocrea, B. Zingarelli, E. Gilard, P. Hake, A.L. Salzman, and C. Szabó Protective effect of melatonin in carrageenin-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity J Pineal Res 23 1997 106 116
23. B.A. Nichols, and D.F. Bainton Differentiation of human monocytes in bone marrow and blood. Sequential formation of two granule populations Lab Invest 29 1973 27 40
24. E. Malle, P.G. Furtmüller, W. Sattler, and C. Obinger Myeloperoxidase: a target for new drug development? Br J Pharmacol 152 2007 838 854
25. S.J. Klebanoff Myeloperoxidase: friend and foe J Leukoc Biol 77 2005 598-625
26. A. Bos, R. Wever, and D. Roos Characterization and quantification of the peroxidase in human monocytes Biochim Biophys Acta 525 1978 37 44
27. P. Peter, M.D. Bradley, A. Dennis, M.D. Priebat, D. Robert, and M.D. Christensen Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J Invest Dermatol 78 1982 206 209
28. S.J. Klebanoff Myeloperoxidase: friend and foe J Leukoc Biol 77 2005 598-25
29. J.S. Deng, C.S. Chi, S.S. Huang, P.H. Shie, T.H. Lin, and G.J. Huang Antioxidant, analgesic, and anti-inflammatory activities of the ethanolic extracts of Taxillus liquidambaricola J Ethnopharmacol 137 2011 1161 1171
30. H. Rubbo, R. Radi, M. Trujillo, R. Telleri, B. Kalyanaraman, and S. Barnes Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation J Biol Chem 269 1994 26066 26075
31. G.J. Huang, C.H. Pan, and C.H. Wu Sclareol exhibits anti-inflammatory activity in both lipopolysaccharide-stimulated macrophages and the λ-carrageenan-induced paw edema model J Nat Prod 75 2012 54 59
32. C. Nanthan Nitric oxide as a secretory product of mammalian cells FASEB J 6 1992 3051 3064
33. J.K. Kundu, and Y.J. Surh Inflammation: gearing the journey to cancer Mutat Res 659 2008 15 30
34. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-κB activity Annu Rev Immunol 18 2000 621 663
35. M.S. Choi, S.H. Lee, H.S. Cho, Y. Kim, Y.P. Yun, and H.Y. Jung Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappa B/MAP kinases in lipopolysaccharide-treated RAW 264.7cells Eur J Pharmacol 556 2007 181 189
36. H.J. Choi, J.S. Eun, Y.R. Park, D.K. Kim, R. Li, and W.S. Moon Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide- stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappa B signaling pathways Eur J Pharmacol 601 2008 171 178
37. B. Zingarelli, M. Sheehan, and H.R. Wong Nuclear factor-kappa B as a therapeutic target in critical care medicine Crit Care Med 31 2003 S105 S111
38. G.L. Johnson, and R. Lapadat Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases Science 298 2002 1911 1912
39. S. Bhattacharyya, P.K. Dudeja, and J.K. Tobacman Carrageenan-induced NF kappa B activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10 Biochim Biophys Acta 1780 2008 973 982
40. J.H. Kim, D.H. Kim, S.H. Baek, H.J. Lee, M.R. Kim, and H.J. Kwon Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappa B and p38 MAP kinase activity in LPS-stimulated RAW264.7 cells Biochem Pharmacol 71 2006 1198 1205
41. S.J. Suh, T.W. Chung, M.J. Son, S.H. Kim, T.C. Moon, and K.H. Son The naturally occurring bioflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappa B regulation, in RAW264.7 cells Arch Biochem Biophys 447 2006 136 146
42. S.J. Ajizian, B.K. English, and E.A. Meals Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma J Infect Dis 179 1999 939 944
43. J.L. Dean, M. Brook, A.R. Clark, and J. Saklatvala p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes J Biol Chem 274 1999 264 269